NeuroOne Medical Technologies (NASDAQ:NMTC) Stock Price Down 9.1% – Here’s What Happened

NeuroOne Medical Technologies Co. (NASDAQ:NMTC)’s stock price fell 9.1% on Thursday . The stock traded as low as $0.72 and last traded at $0.76. 393,704 shares were traded during trading, an increase of 196% from the average session volume of 133,201 shares. The stock had previously closed at $0.84.

NeuroOne Medical Technologies Price Performance

The company has a 50 day moving average price of $0.83 and a 200-day moving average price of $0.84. The company has a market cap of $23.42 million, a price-to-earnings ratio of -1.58 and a beta of 0.54.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in NeuroOne Medical Technologies stock. Geode Capital Management LLC boosted its position in NeuroOne Medical Technologies Co. (NASDAQ:NMTC) by 9.6% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 283,855 shares of the company’s stock after buying an additional 24,972 shares during the period. Geode Capital Management LLC owned approximately 0.92% of NeuroOne Medical Technologies worth $281,000 at the end of the most recent quarter. Hedge funds and other institutional investors own 16.07% of the company’s stock.

NeuroOne Medical Technologies Company Profile

NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders.